← Evidence map

ArticleThe Journal of antimicrobial chemotherapy2018

Small increase in dolutegravir trough, but equivalent total dolutegravir exposure with simeprevir in HIV/HCV seronegative volunteers.

Christine E MacBrayne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2018
2019
2020
2021
2022
2023
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 29029135